BRILIA

Welcome to the Brand page for “BRILIA”, which is offered here for Human pharmaceutical preparations for the treatment of anti-viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, infectious-related diseases, metabolic diseases, gastrointestinal diseases, muscle dystonias, wrinkles and smooth muscle disorders, oncologic diseases, ophthalmic diseases, respiratory diseases; vaccines; and hemostatic agents;.

Its status is currently believed to be active. Its class is unavailable. “BRILIA” is believed to be currently owned by “JANSSEN R&D IRELAND”.